Application 206302
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BYVALSON | NEBIVOLOL HYDROCHLORIDE; VALSARTAN | TABLET;ORAL | EQ 5MG BASE;80MG | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0023-5874 | Byvalson | nebivolol hydrochloride and valsartan | Allergan, Inc. | NDA | Current |